pembrolizumab
merck
['lung', 'pembro']
michael seckl ( ) is at #asco preseting from 8am cdt on refine-lung: a multicentre phase iii study to determine the optimal frequency of pembrolizumab in non-small cell #lungcancer utilising a novel multi-arm design: #crukfunded
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK